Skip to main content

Articles

Page 2 of 74

  1. Atypical meningioma (AM) has a high recurrence rate. This study explored the factors associated with recurrence and built a predictive model for AM by combining radiomic and clinical features.

    Authors: Dengpan Song, Qingjie Wei, Shengqi Zhao, Yuanhao Lou, Kaiyuan Zhang, Chengcheng Duan, Fang Wang, Qiang Gao, Jing Yan, Dongming Yan, Yuchao Zuo and Fuyou Guo
    Citation: Radiation Oncology 2025 20:30
  2. Cancer associated fibroblasts have become a target of interest in different malignancies for positron emission tomography (PET) imaging, using positron emitter labelled fibroblast activation protein inhibitors...

    Authors: Kai Kröger, Niklas Benedikt Pepper, David Ventura, Fabian M. Troschel, Philipp Backhaus, Kambiz Rahbar, Bernhard Glasbrenner, Matthias Brüwer, Andreas Pascher, Michael Schäfers, Hans Theodor Eich and Wolfgang Roll
    Citation: Radiation Oncology 2025 20:29
  3. Glioblastomas all eventually relapse after initial treatment, and an option to treat these recurrences is fractionated stereotactic reirradiation (fSRT). The location of recurrences following reirradiation has...

    Authors: Agathe Margulies, Nassim Sahki, Fabien Rech, Guillaume Vogin, Marie Blonski, Didier Peiffert, Luc Taillandier, Grégory Lesanne and Nicolas Demogeot
    Citation: Radiation Oncology 2025 20:28
  4. The study aimed to create a radiomics model based on breast intra- and peri-tumoral regions in dynamic contrast-enhanced (DCE) MRI to distinguish benign from malignant breast lesions of Breast Imaging Reportin...

    Authors: Yalan Hu, Zhenhai Cai, Nijiati Aierken, Yueqi Liu, Nan Shao, Yawei Shi, Mengmeng Zhang, Yangling Hu, Xiaoling Zhang and Ying Lin
    Citation: Radiation Oncology 2025 20:27
  5. Deformable registration plays an important role in the accurate delineation of tumors. Most of the existing deep learning methods ignored two issues that can lead to inaccurate registration, including the limi...

    Authors: Yi Guo, Jun Chen, Lin Lu, Lingna Qiu, Linzhen Lan, Feibao Guo and Jinsheng Hong
    Citation: Radiation Oncology 2025 20:26
  6. External beam radiotherapy (EBRT) is a standard treatment for localized prostate cancer, with recent advancements favoring a reduced number of treatment sessions. Stereotactic body radiotherapy (SBRT) is a for...

    Authors: Brecht De Cooman, Tibaut Debacker, Thomas Adams, Guy Lamberts, Bart De Troyer, Marc Claessens, Geert De Kerf, Carole Mercier, Piet Dirix and Piet Ost
    Citation: Radiation Oncology 2025 20:25
  7. This study aimed to analyze the effect of target volumes for radiotherapy and dose on the prognosis of high-grade glioma (HGG) patients when the tumor involves the subventricular zone (SVZ), and to provide a r...

    Authors: Fei Sun, Yan Zhu, Guanghui Gan, Yuan Xu and Xiaoting Xu
    Citation: Radiation Oncology 2025 20:24
  8. Liver cancer is the third leading cause of cancer related death due to treatment resistance and late onset of symptoms (Rumgay in J Hepatol 77: 1598–1606, 2022). The role of external beam radiotherapy (EBRT) i...

    Authors: Paula Hoffmeister-Wittmann, Philipp Hoegen-Saßmannshausen, Livia Wicklein, Fabian Weykamp, Katharina Seidensaal, Christoph Springfeld, Michael T. Dill, Thomas Longerich, Peter Schirmacher, Arianeb Mehrabi, René Michael Mathy, Bruno C. Köhler, Jürgen Debus, Klaus Herfarth and Jakob Liermann
    Citation: Radiation Oncology 2025 20:23
  9. Preservation of visual acuity remains a challenging issue after globe sparing therapy of large uveal melanoma. The aim of our study was analyzing the functional outcome after brachytherapy with bi-nuclide plaq...

    Authors: Leyla Jabbarli, Miltiadis Fiorentzis, Philipp Rating, Boerge Schmidt, Eva Biewald, Nika Guberina, Dirk Flühs, Norbert Bornfeld, Wolfgang Sauerwein, Martin Stuschke, Nikolaos E. Bechrakis and Maja Guberina
    Citation: Radiation Oncology 2025 20:22
  10. This single-arm phase II trial aimed to assess the effectiveness and safety of incorporating hyperthermia into salvage concurrent chemoradiotherapy (CCRT) for previously irradiated unresectable recurrent head ...

    Authors: Kai-Lin Yang, Mau-Shin Chi, Chung-Yu Hao, Hui-Ling Ko, Yi-Ying Huang, Ren-Hong Wu, Hung-Chih Lai, Ying-Chu Lin, Sheng-Po Hao and Kwan-Hwa Chi
    Citation: Radiation Oncology 2025 20:21
  11. Lung cancer patients with comorbid interstitial lung disease (LC-ILD) have an increased risk of developing severe or even fatal radiation pneumonitis after thoracic radiotherapy. However, the underlying mechan...

    Authors: Jiamei Fu, Xinglong Liu, Yuchuan Zhou, Shengnan Zhao, Liang Zeng, Yan Pan, Jianghong Zhang, Kevin M. Prise, Chunlin Shao and Yaping Xu
    Citation: Radiation Oncology 2025 20:20
  12. Stereotactic Body Radiation Therapy (SBRT) is a safe and effective treatment for liver metastases or hepatocellular carcinoma (HCC) with a dose–response relationship for local control (LC). Proximity to organs...

    Authors: Alizée Renan, Marie Bruand, Maria Jolnerovski, Aboubacar Diallo and Nicolas Demogeot
    Citation: Radiation Oncology 2025 20:19
  13. This study evaluated StarGAN, a deep learning model designed to generate synthetic computed tomography (sCT) images from magnetic resonance imaging (MRI) and cone-beam computed tomography (CBCT) data using a s...

    Authors: Paritt Wongtrakool, Chanon Puttanawarut, Pimolpun Changkaew, Supakiet Piasanthia, Pareena Earwong, Nauljun Stansook and Suphalak Khachonkham
    Citation: Radiation Oncology 2025 20:18
  14. Medulloblastoma is the most common malignant pediatric brain tumor, typically treated with normofractionated craniospinal irradiation (CSI) with an additional boost over about 6 weeks in children older than 3 ...

    Authors: Danny Jazmati, Dennis Sohn, Juliane Hörner-Rieber, Nan Qin, Edwin Bölke, Jan Haussmann, Rudolf Schwarz, Niklas David Niggemeier, Arndt Borkhardt, Florian Babor, Triantafyllia Brozou, Melissa Felek, Balint Tamaskovics, Patrick Melchior, Thomas Beez, Beate Timmermann…
    Citation: Radiation Oncology 2025 20:17
  15. Radiotherapy as a complement or an alternative to neurosurgery has a central role in the treatment of skull base grade I-II meningiomas. Radiotherapy techniques have improved considerably over the last two dec...

    Authors: Paul Lesueur, Florence Joly, Benedicte Clarisse, Justine Lequesne, Dinu Stefan, Jacques Balosso, Marie Lange, Sebastien Thureau, Aurelie Capel, Marie Castera, Berenice Legrand, Nicolas Goliot, Jean Michel Grellard, Thomas Tessonnier, Helene Castel and Samuel Valable
    Citation: Radiation Oncology 2025 20:16

    The Correction to this article has been published in Radiation Oncology 2025 20:67

  16. For radiotherapy of head and neck cancer (HNC) magnetic resonance imaging (MRI) plays a pivotal role due to its high soft tissue contrast. Moreover, it offers the potential to acquire functional information th...

    Authors: Simon Boeke, Jonas Habrich, Sarah Kübler, Jessica Boldt, Fritz Schick, Konstantin Nikolaou, Jens Kübler, Cihan Gani, Maximilian Niyazi, Daniel Zips and Daniela Thorwarth
    Citation: Radiation Oncology 2025 20:15
  17. The impact of radiation-related lymphocyte recovery on prognosis in locally advanced esophageal squamous cell carcinoma (LA-ESCC) remains unclear.

    Authors: Hongshan Ji, Ping Zhang, Chanjun Zhen, Liyuan Fu, Dongjie Lv, Wenwen Bai, Rui Zhang, Jing Li, Hang Gao, Yajing Wang, Qiuying An, Yuhao Su, Hanyu Si, Xueying Qiao and Zhiguo Zhou
    Citation: Radiation Oncology 2025 20:14
  18. Authors: Céline Meyer, Sandrine Huger, Marie Bruand, Thomas Leroy, Jérémy Palisson, Paul Rétif, Thomas Sarrade, Anais Barateau, Sophie Renard, Maria Jolnerovski, Nicolas Demogeot, Johann Marcel, Nicolas Martz, Anaïs Stefani, Selima Sellami, Juliette Jacques…
    Citation: Radiation Oncology 2025 20:13

    The original article was published in Radiation Oncology 2024 19:168

  19. Conventional radiotherapy (CRT) has limited local control and poses a high risk of severe toxicity in large lung tumors. This study aimed to develop an integrated treatment plan that combines CRT with lattice ...

    Authors: Hongwei Zeng, Xiangyu E, Minghe Lv, Su Zeng, Yue Feng, Wenhao Shen, Wenhui Guan, Yang Zhang, Ruping Zhao and Jingping Yu
    Citation: Radiation Oncology 2025 20:12
  20. Authors: Chao Wei, Jie Kong, Huina Han, Xue Wang, Zimeng Gao, Danyang Wang, Andu Zhang, Jun Zhang and Zhikun Liu
    Citation: Radiation Oncology 2025 20:11

    The original article was published in Radiation Oncology 2024 19:120

  21. To determine the dosimetric effects of set-up errors on boost coverage, and compares skin toxicity of sequential and simultaneous boost techniques for left-sided breast cancer.

    Authors: Changyou Zhong, Minfeng Huang, Haidong Yu, Jun Yuan, Ruilian Xie, Zhenzhen Lai, Shanzhou Niu and Chunbo Tang
    Citation: Radiation Oncology 2025 20:10
  22. Several studies have suggested that lung tissue heterogeneity is associated with overall survival (OS) in lung cancer. However, the quantitative relationship between the two remains unknown. The purpose of thi...

    Authors: Meng Yan, Zhen Zhang, Jia Tian, Jiaqi Yu, Andre Dekker, Dirk de Ruysscher, Leonard Wee and Lujun Zhao
    Citation: Radiation Oncology 2025 20:9
  23. Treatment record contains most of information related to treatment plan delivery in radiation therapy. Reviewing treatment record is an important quality assurance (QA) task for safety and quality of patient t...

    Authors: Peng Huang, Yingjie Xu, Fukui Huan, Yanxin Zhang, Min Ma, Kuo Men and Jianrong Dai
    Citation: Radiation Oncology 2025 20:8
  24. Proton beam therapy (PBT) has been gradually introduced for treating choroidal melanoma. This study systematically reviewed clinical reports to evaluate the efficacy and safety of PBT in choroidal melanoma pat...

    Authors: Yuxin Miao, Tingwei Zheng, Qiuning Zhang, Meixuan Li, Qihang Lei, Qin Liu, Hongtao Luo and Huiling Bai
    Citation: Radiation Oncology 2025 20:7
  25. Patients with non-small cell lung cancer (NSCLC) are prone to developing brain metastases (BMs), particularly those with epidermal growth factor receptor (EGFR) mutations. In clinical practice, treatment-naïve...

    Authors: Mingfeng He, Xue Wu, Li Li, Guangming Yi, Yitian Wang, Hengqiu He, Ying Ye, Ruiqin Zhou, Zaicheng Xu and Zhenzhou Yang
    Citation: Radiation Oncology 2025 20:6
  26. To characterize the differences of dynamic changes for absolute lymphocyte count (ALC) among esophageal squamous cell carcinoma (ESCC) patients treated with neoadjuvant chemoradiotherapy (nCRT) with or without...

    Authors: Wei-Xiang Qi, Shuyan Li, Shujun Zhang, Chao Li, Huan Li, Xiaomei Li, Chaofen Zhao, Gang Cai, Cheng Xu, Xuan Han, Yibin Zhang, Jiayi Chen and Shengguang Zhao
    Citation: Radiation Oncology 2025 20:5
  27. In this retrospective study, we aimed to evaluate the efficacy and incidence of radiation-induced brain necrosis (RBN) after volumetric modulated arc therapy-based stereotactic irradiation (VMAT-STI) for brain me...

    Authors: Takayuki Ohguri, Hirohide Itamura, Subaru Tani, Eiji Shiba and Junkoh Yamamoto
    Citation: Radiation Oncology 2025 20:4
  28. Based on the demonstration of a circadian rhythm in the human oral mucosa cell cycle, with most cells in the G2/M phase in the afternoon and at night, the present study evaluated the severity of acute radiatio...

    Authors: Yun Xing, Yutian Yin, Liang Yu, Cong Zhang, Guangjin Chai, Bo Lyu, Bin Wang, Lina Zhao and Geng Xiang
    Citation: Radiation Oncology 2025 20:3
  29. Stage IV non-small cell lung carcinoma (NSCLC) with oligometastases is potentially curable by radical treatment. This study aimed to evaluate the efficacy and safety of chemoradiotherapy (CRT) for thoracic dis...

    Authors: Takaaki Tokito, Kazuhiko Yamada, Hidenobu Ishii, Yuichi Takiguchi, Go Saito, Koichi Minato, Hisao Imai, Hiroshi Tanaka, Satoru Miura, Kageaki Watanabe, Yoshifusa Koreeda, Akira Ono, Naoki Furuya, Toshihiro Misumi, Kazushige Hayakawa, Etsuyo Ogo…
    Citation: Radiation Oncology 2025 20:2
  30. Locoregional recurrence (LR) is common in locally advanced head and neck cancer (HNSCC), posing challenges for treatment. We analysed outcome parameters and toxicities for patients being treated with radiothe...

    Authors: Julia Katharina Schleifenbaum, Janis Morgenthaler, Shachi Jenny Sharma, Jens Peter Klußmann, Philipp Linde, Simone Wegen, Johannes Rosenbrock, Christian Baues, Emmanouil Fokas, Richard Khor, Sweet Ping Ng, Simone Marnitz and Maike Trommer
    Citation: Radiation Oncology 2025 20:1
  31. Timely identification of local failure after stereotactic radiotherapy for brain metastases allows for treatment modifications, potentially improving outcomes. While previous studies showed that adding radiomi...

    Authors: Hemalatha Kanakarajan, Wouter De Baene, Patrick Hanssens and Margriet Sitskoorn
    Citation: Radiation Oncology 2024 19:182
  32. To investigate the early predictive value of dynamic magnetic resonance imaging (MRI)-based radiomics for progression and prognosis in locally advanced cervical cancer (LACC) patients treated with concurrent c...

    Authors: Chang Cai, Ji-Feng Xiao, Rong Cai, Dan Ou, Yi-Wei Wang, Jia-Yi Chen and Hao-Ping Xu
    Citation: Radiation Oncology 2024 19:181
  33. Laryngeal cancer is a common head and neck cancer. Surgical treatment can impair patients’ voice and swallowing function, making definitive radiotherapy a viable alternative for locally advanced cases.

    Authors: Ali Kazemian, Ebrahim Esmati, Reza Ghalehtaki, Borna Farazmand, Nima Mousavi-Darzikolaee, Reyhaneh Bayani, Mahdieh Razmkhah, Maryam Taherioun, Niloufar Saeedi, Farrokh Heidari and Kaveh Zakeri
    Citation: Radiation Oncology 2024 19:180
  34. Rectal cancer patients are potential beneficiaries of adaptive radiotherapy (ART) which demands considerable resources. Currently, there is no definite guidance on what kind of patients and when will benefit f...

    Authors: Liyuan Chen, Lei Yu, Huanli Luo, Yanju Yang, Zhen Zhang, Fu Jin, Weigang Hu and Jiazhou Wang
    Citation: Radiation Oncology 2024 19:179
  35. This study evaluates the dosimetric impact of tumor matching (TM) and bone matching (BM) in carbon ion radiotherapy for locally advanced non-small cell lung cancer.

    Authors: Jing Mi, Shubin Jia, Liyuan Chen, Yaqi Li, Jiayao Sun, Liwen Zhang, Jingfang Mao, Jian Chen, Ningyi Ma, Jingfang Zhao and Kailiang Wu
    Citation: Radiation Oncology 2024 19:178
  36. This study aims to investigate the prognostic impact of ground-glass opacity (GGO)-component in early-stage lung cancer patients treated with stereotactic body radiotherapy (SBRT).

    Authors: Jintao Ma, Shaonan Fan, Wenhan Huang, Xiaohong Xu, Yong Hu and Jian He
    Citation: Radiation Oncology 2024 19:177
  37. The purpose of this study was to quantify the intra- and interfraction motion of the target volume and organs at risk (OARs) during adaptive radiotherapy (ART) for uterine cervical cancer (UCC) using MR-Linac ...

    Authors: Huadong Wang, Zhenkai Li, Dengxin Shi, Peijun Yin, Benzhe Liang, Jingmin Zou, Qiuqing Tao, Wencheng Ma, Yong Yin and Zhenjiang Li
    Citation: Radiation Oncology 2024 19:176
  38. While there is a growing amount of data on the cardiac toxicity of radiotherapy (RT) in relation to its impact on cardiac sub-structures (CSS), there are only few studies addressing this issue in patients foll...

    Authors: Victor Nguyen, Jean-Philippe Metges, Moncef Morjani, Pierre-Guillaume Pourreau, Estelle Dhamelincourt, Lucille Quenehervé, Olivier Pradier and Vincent Bourbonne
    Citation: Radiation Oncology 2024 19:175
  39. Local recurrence of rectal cancer (LRRC) previously treated with radiotherapy is associated with a poor prognosis. Historically, the integration of radiotherapy (RT) with surgery has improved the likelihood of...

    Authors: Maria Antonietta Gambacorta, Angela Romano, Luciana Caravatta, Gabriella Macchia, Giuditta Chiloiro, Elena Galofaro, Francesca Valvo, Viviana Vitolo, Daniela Alterio and Giovanna Mantello
    Citation: Radiation Oncology 2024 19:174
  40. The use of stereotactic body radiotherapy (SBRT) to definitively treat oligometastases in prostate cancer has drawn large clinical and research interests within radiation oncology. However, the evidence is con...

    Authors: Astrid E. Persson, Andreas Hallqvist, Louise Bjørn Larsen, Mette Rasmussen, Jonas Scherman, Per Nilsson, Hanne Tønnesen and Adalsteinn Gunnlaugsson
    Citation: Radiation Oncology 2024 19:173
  41. Current approaches for locally advanced rectal cancer (LARC) typically recommend neoadjuvant chemoradiotherapy (nCRT) with 5-fluorouracil (5FU) or its oral analogs followed by surgery as the standard of care. ...

    Authors: Amirali Azimi, Fatemeh Sadat Tabatabaei, Kasra Kolahdouzan, Hamideh Rashidian, Forouzan Nourbakhsh, Maryam Abedini Parizi, Nima Mousavi Darzikolaee, Reyhaneh Bayani, Samaneh Salarvand, Azadeh Sharifian, Farzaneh Bagheri, Saeed Rezaei, Naeim Nabian, Reza Nazari, Negin Mohammadi, Mohammad Babaei…
    Citation: Radiation Oncology 2024 19:172
  42. Antipsychotic drugs (APDs) are used for treating mental illnesses and are also used by cancer patients. This study aimed to evaluate APD use in adult cancer patients who received radiotherapy (RT) in South Kor...

    Authors: In Gyu Hwang, Song E Park, Sun Mi Kim, Dae Ryong Kang, Tae-Hwa Go, Se Hwa Hong, Yong-Chan Ha, Shin Young Park, Hyunho Lee and Jin Hwa Choi
    Citation: Radiation Oncology 2024 19:171
  43. Accurate calculation of lung cancer dose using the Monte Carlo (MC) algorithm in CyberKnife (CK) is essential for precise planning. We aim to employ deep learning to directly predict the 3D dose distribution c...

    Authors: Yuchao Miao, Jiwei Li, Ruigang Ge, Chuanbin Xie, Yaoying Liu, Gaolong Zhang, Mingchang Miao and Shouping Xu
    Citation: Radiation Oncology 2024 19:170
  44. Post-Therapy-Pneumonitis (PTP) is a critical side effect of both, thoracic radio(chemo)therapy (R(C)T) and immune checkpoint inhibition (ICI). However, disease characteristics and patient-specific risk factors...

    Authors: Kim Melanie Kraus, Caroline Bauer, Lisa Steinhelfer, Benedikt Feuerecker, Juliana Cristina Martins, Julius Clemens Fischer, Kai Joachim Borm, Jan Caspar Peeken, Denise Bernhardt and Stephanie Elisabeth Combs
    Citation: Radiation Oncology 2024 19:169
  45. The delineation of organs-at-risk and lymph node areas is a crucial step in radiotherapy, but it is time-consuming and associated with substantial user-dependent variability in contouring. Artificial intellige...

    Authors: Céline Meyer, Sandrine Huger, Marie Bruand, Thomas Leroy, Jérémy Palisson, Paul Rétif, Thomas Sarrade, Anais Barateau, Sophie Renard, Maria Jolnerovski, Nicolas Demogeot, Johann Marcel, Nicolas Martz, Anaïs Stefani, Selima Sellami, Juliette Jacques…
    Citation: Radiation Oncology 2024 19:168

    The Correction to this article has been published in Radiation Oncology 2025 20:13

  46. Metastatic prostate cancer remains a therapeutic challenge. Based on data of the STAMPEDE trial, patients with a low metastatic burden showed prolonged failure-free and overall survival when treated with prost...

    Authors: Kristina K. M. Kramer, Nina-Sophie Schmidt-Hegemann, Thilo Westhofen, Marco Foglar, Jens Ricke, C. Benedikt Westphalen, Marcus Unterrainer, Wolfgang G. Kunz and Dirk Mehrens
    Citation: Radiation Oncology 2024 19:167
  47. During the day-night cycle, gravity and applied stress to the body mass and spine causes a decrease in body height, which is restored overnight. This diurnal spine length variation has not yet been quantified ...

    Authors: Karin M. Meijer, Irma W.E.M. van Dijk, Tamara J. Schonk, Brian V. Balgobind, Anna Loginova, Niek van Wieringen and Arjan Bel
    Citation: Radiation Oncology 2024 19:166
  48. The potential of carbon ion radiation therapy (CIRT) as a curative treatment for localized prostate cancer (PCa) has garnered attention due to its characteristic dose distribution. We prospectively collected a...

    Authors: Yoshiyuki Miyazawa, Hiroshi Nakayama, Hidemasa Kawamura, Yuhei Miyasaka, Masahiro Onishi, Takuya Kaminuma, Yoshitaka Sekine, Hiroshi Matsui, Tatsuya Ohno and Kazuhiro Suzuki
    Citation: Radiation Oncology 2024 19:165
  49. The present study aimed to evaluate the use of 18F-2-[18F]-fluoro-2-deoxy-d-glucose (FDG) PET/MRI (Positron emission tomography-computed tomography) in predicting the pathological response to neoadjuvant chemothe...

    Authors: Milad Ghanikolahloo, Hayder Jasim Taher, Ayoob Dinar Abdullah, Mahsa Asadi Anar, Ali Tayebi, Rahil Rahimi, Faranak Olamaeian, Nima Rahimikashkooli and Nima Kargar
    Citation: Radiation Oncology 2024 19:164
  50. The purpose of this study is to assess the feasibility of mixed-reality (MixR) visualization for patient setup in breast and chest wall radiotherapy (RT) by performing a first-in-human clinical trial comparing...

    Authors: Perry B. Johnson, Julie Bradley, Samsun Lampotang, Amanda Jackson, David Lizdas, William Johnson, Eric Brooks, Raymond B. Mailhot Vega and Nancy Mendenhall
    Citation: Radiation Oncology 2024 19:163

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 3.3
    5-year Journal Impact Factor: 3.6
    Source Normalized Impact per Paper (SNIP): 1.197
    SCImago Journal Rank (SJR): 1.033

    Speed 2024
    Submission to first editorial decision (median days): 16
    Submission to acceptance (median days): 135

    Usage 2024
    Downloads: 2,096,424
    Altmetric mentions: 233